CBT
AGN

Central Bank & Trust’s Allergan plc AGN Stock Holding History

Central Bank & Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-87
Closed -$15K – 294
2019
Q3 		$15K Buy
+87
New +$14.2K ﹤0.01% 219
2019
Q1 		– Sell
-27
Closed -$4K – 287
2018
Q4 		$4K Hold
27
– – ﹤0.01% 256
2018
Q3 		$5K Hold
27
– – ﹤0.01% 253
2018
Q2 		$5K Hold
27
– – ﹤0.01% 251
2018
Q1 		$5K Sell
27
-11,393
-100% -$1.91M ﹤0.01% 247
2017
Q4 		$1.87M Sell
11,420
-2,294
-17% -$412K 0.45% 67
2017
Q3 		$2.81M Buy
13,714
+2,031
+17% +$472K 0.7% 53
2017
Q2 		$2.84M Sell
11,683
-337
-3% -$79.2K 0.74% 51
2017
Q1 		$2.87M Sell
12,020
-1,762
-13% -$410K 0.74% 49
2016
Q4 		$2.89M Sell
13,782
-7,707
-36% -$1.6M 0.77% 49
2016
Q3 		$4.95M Sell
21,489
-2,524
-11% -$617K 1.39% 22
2016
Q2 		$5.55M Sell
24,013
-12,973
-35% -$2.99M 1.6% 19
2016
Q1 		$9.91M Sell
36,986
-1,436
-4% -$411K 2.77% 4
2015
Q4 		$12M Buy
38,422
+1,105
+3% +$329K 3.47% 3
2015
Q3 		$10.1M Buy
37,317
+2,710
+8% +$832K 3.35% 3
2015
Q2 		$10.5M Sell
34,607
-1,165
-3% -$347K 3.34% 2
2015
Q1 		$10.6M Buy
35,772
+6,398
+22% +$1.82M 3.54% 2
2014
Q4 		$7.56M Sell
29,374
-509
-2% -$127K 2.59% 6
2014
Q3 		$7.21M Sell
29,883
-1,099
-4% -$246K 2.73% 3
2014
Q2 		$5.21M Buy
30,982
+338
+1% +$70K 2.01% 5
2014
Q1 		$6.31M Sell
30,644
-338
-1% -$67K 2.46% 3
2013
Q4 		$5.21M Buy
30,982
+2,244
+8% +$351K 2.01% 5
2013
Q3 		$4.14M Buy
28,738
+944
+3% +$126K 1.85% 7
2013
Q2 		$3.51M Buy
+27,794
New +$3.15M 1.67% 11

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Central Bank & Trust's AGN Position: Q4 2019 in Review

Central Bank & Trust sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 87 shares — an estimated $15K sold.

Central Bank & Trust first reported a position in AGN in Q2 2013 and held it in 24 quarters. The position peaked at $12M in Q4 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Central Bank & Trust reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Central Bank & Trust sold 87 Allergan plc shares in Q4 2019, an estimated $15K.
  • Central Bank & Trust first reported a position in Allergan plc in Q2 2013 and held it in 24 quarters.
  • Central Bank & Trust's Allergan plc position peaked at $12M in Q4 2015.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Central Bank & Trust's 13F filing for Q4 2019, filed 13 Jan 2020.